RJA
PBH icon

Ross\Johnson & Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Ross\Johnson & Associates’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8
Closed -$494 – 311
2025
Q4 		$494 Buy
+8
New +$490 0.01% 156

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ross\Johnson & Associates's PBH Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 8 shares — an estimated $494 sold.

Ross\Johnson & Associates first reported a position in PBH in Q4 2025 and held it in 1 quarter. The position peaked at $494 in Q4 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Ross\Johnson & Associates reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Ross\Johnson & Associates sold 8 Prestige Consumer Healthcare shares in Q1 2026, an estimated $494.
  • Ross\Johnson & Associates first reported a position in Prestige Consumer Healthcare in Q4 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Prestige Consumer Healthcare position peaked at $494 in Q4 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.